New Treatment for Patients with XXX Cancer

We are exploring a new combination therapy for people with XXX cancer who need a second-line treatment. The goal is to see if this approach is safer and more effective than standard care.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Clinica Universidad De Navarra
Medical Oncology
Barañáin, Spain
Hospital Universitario Hm Sanchinarro
Medical Oncology
Chamartín, Spain
Clinica Universidad De Navarra
Medical Oncology
Ciudad Lineal, Spain

Sponsor: NovImmune S.A.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.